Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Validation of Version 3.0 of the Breast Cancer Genetics Referral Screening Tool (B-RST™).

Genetics in medicine : official journal of the American College of Medical Genetics - 1 Jan 2019

Bellcross Cecelia, Hermstad April, Tallo Christine, Stanislaw Christine

Abstract excerpt

PURPOSE: Despite increased awareness of hereditary breast and ovarian cancer among clinicians and the public, many BRCA1/2 mutation carriers remain unaware of their risk status. The Breast Cancer Genetics Referral Screening Tool (B-RST™) was created and validated to easily identify individuals at increased risk for hereditary breast and ovarian cancer for referral to cancer genetics services. The purpose of this...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Aged
Share to BRCA1 Protein

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to BRCA2 Protein

Share to Breast Neoplasms

Share to Early Detection of Cancer

Share to Genetic Testing

Share to Ovarian Neoplasms

Share to Pedigree

Source

Identifiers

PMID: 29740170
DOI: 10.1038/s41436-018-0020-x

Genes

BRCA1

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Validation of Version 3.0 of the Breast Cancer Genetics Referral Screening Tool (B-RST™).PMID 29740170Read ↗

Evaluating the NCCN Clinical Criteria for Recommending BRCA1 and BRCA2 Genetic Testing in Patients With Breast Cancer.Semantic proximity Read ↗

Evaluation of the Dutch BRCA1/2 clinical genetic center referral criteria in an unselected early breast cancer population.Semantic proximity Read ↗

Evaluation of a breast/ovarian cancer genetics referral screening tool in a mammography population.Semantic proximity Read ↗

Adherence patterns to National Comprehensive Cancer Network (NCCN) guidelines for referral to cancer genetic professionals.Semantic proximity Read ↗

Validation of the pedigree assessment tool (PAT) in families with BRCA1 and BRCA2 mutations.Semantic proximity Read ↗

Increasing referral of at-risk women for genetic counseling and BRCA testing using a screening tool in a community breast imaging center.Semantic proximity Read ↗

Mainstream Germline Genetic Testing with Expanded Eligibility for Early Breast Cancer Patients in a Large Integrated Health System.Semantic proximity Read ↗

BRCA1/2 testing in newly diagnosed breast and ovarian cancer patients without prior genetic counselling: the DNA-BONus study.Semantic proximity Read ↗

Adherence to NCCN Guidelines for Genetic Testing in Breast Cancer Patients: Who Are We Missing?Semantic proximity Read ↗

Universal genetic counseling in breast cancer patients significantly improves overall testing rates and improves completion rates in subpopulations.Semantic proximity Read ↗

Implementing a screening tool for identifying patients at risk for hereditary breast and ovarian cancer: a statewide initiative.Semantic proximity Read ↗

BRCAsearch: written pre-test information and BRCA1/2 germline mutation testing in unselected patients with newly diagnosed breast cancer.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.